Ouvrages publiés en collaboration (1)
1.
Mendlewicz, J., Lotstra, F., Souery, D., Massat, I., Oswald, P., Linkowski, P., Braun, S., Bauwens, F., Merinfeld, E., Nef, F., & Pardoen, D. (2007). La Dépression, un mal de vivre, des solutions. Editions Du Seuil. Parties d'ouvrages collectifs (4)
3.
Souery, D., Lipp, O., Massat, I., & Mendlewicz, J. (2001). The characterization and definition of treatment-resistant mood disorders. In J. Amsterdam, M. Horing, & A. Nierenberg (Eds.), Treatment-resistant mood disorders (pp. 3-29). Cambridge University Press. Articles dans des revues avec comité de lecture (220)
1.
Kraus, C., Kautzky, A., Watzal, V., Gramser, A., Kadriu, B., Deng, Z. D., Bartova, L., Zarate, C. C., Lanzenberger, R., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Fanelli, G., Serretti, A., & Kasper, S. S. (2023). Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database. Journal of affective disorders, 335, 349-357. doi:10.1016/j.jad.2023.05.0422.
Bartova, L., Fugger, G., Dold, M., Kautzky, A., Fanelli, G., Zanardi, R., Albani, D., Weidenauer, A., Rujescu, D., Souery, D., Mendlewicz, J., Montgomery, S., Zohar, J., Fabbri, C., Serretti, A., & Kasper, S. S. (2023). Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder. Journal of affective disorders, 332, 105-114. doi:10.1016/j.jad.2023.03.0683.
Kautzky, A., Bartova, L., Fugger, G., Dold, M., Souery, D., Montgomery, S., Zohar, J., Mendlewicz, J., Fabbri, C., Serretti, A., Rujescu, D., & Kasper, S. S. (2023). Age as a moderating factor of treatment resistance in depression. European psychiatry, 66(1), e35. doi:10.1192/j.eurpsy.2023.174.
Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Zanardi, R., Dold, M., Kautzky, A., Rujescu, D., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., Serretti, A., & Kasper, S. S. (2022). The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs. Journal of affective disorders, 312, 225-234. doi:10.1016/j.jad.2022.06.0045.
Fanelli, G., Sokolowski, M., Wasserman, D., Kasper, S. S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., De Ronchi, D., Serretti, A., & Fabbri, C. (2022). Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideation. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 189(3-4), 74-85. doi:10.1002/ajmg.b.328916.
Fugger, G., Bartova, L., Dold, M., Fabbri, C., Fanelli, G., Zanardi, R., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Rujescu, D., Serretti, A., & Kasper, S. S. (2022). Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 114, 110480. doi:10.1016/j.pnpbp.2021.1104807.
Calabrò, M., Fabbri, C., Kasper, S. S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., De Ronchi, D., Serretti, A., & Crisafulli, C. (2022). Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study. European neuropsychopharmacology, 56, 100-111. doi:10.1016/j.euroneuro.2022.01.008